Hannah A. Valantine, M.D.
Board Member
BridgeBio Pharma, Inc. (BBIO)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Hannah A. Valantine, M.D.
Hannah A. Valantine, M.D. is recorded as Board Member at BridgeBio Pharma, Inc. (BBIO). BridgeBio Pharma, Inc. reported in an 8-K filed June 26, 2026 that Hannah A. Valantine, M.D. was appointed Class I director.
“The Company's stockholders elected the three (3) director nominees below to the Company's Board of Directors as Class I directors to hold office until the 2029 Annual Meeting of Stockholders of the Company or until their successors are duly elected and qualified.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2026-06-26–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at BridgeBio Pharma, Inc.
Other people whose current roles at this company are on record from its filings.
- Neil Kumar CEO, Board Member
- Charles Homcy Chairman, Board Member
- Brian Stephenson CFO
- Thomas Trimarchi CFO, COO
- Brian Stolz COO
- Brian C. Stephenson Chief Accounting Officer
- Ali J. Satvat Board Member
- Andrea Ellis Board Member
- Andrea J. Ellis Board Member
- Andrew W. Lo Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.